agilon health, inc. Financing Cash Flow
agilon health, inc. (AGL) reported Financing Cash Flow of -$516.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- agilon health, inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $4.63M.
- agilon health, inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$5.15M.
- agilon health, inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$17.00K.
- agilon health, inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$236.00K.
- agilon health, inc. net cash provided by (used in) financing activities for fiscal 2025 was -$2.99M.
- agilon health, inc. net cash provided by (used in) financing activities for fiscal 2024 was -$2.58M.
- agilon health, inc. net cash provided by (used in) financing activities for fiscal 2023 was -$193.13M, a 788.38% decline from fiscal 2022.
- agilon health, inc. net cash provided by (used in) financing activities for fiscal 2022 was $28.06M, a 97.57% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$516.00K 10-Q · filed 2026-08-05 | -$533.00K derived: sum of 3 quarters · filed 2026-08-05 | -$769.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$5.15M 10-Q · filed 2026-05-06 | -$5.16M derived: sum of 2 quarters · filed 2026-05-06 | -$5.40M derived: sum of 3 quarters · filed 2026-05-06 | -$7.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$253.00K derived: sum of 2 quarters · filed 2026-02-25 | -$2.83M derived: sum of 3 quarters · filed 2026-08-05 | -$2.99M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$2.82M derived: sum of 2 quarters · filed 2026-08-05 | -$2.98M 10-Q · filed 2025-11-04 | -$3.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.74M 10-Q · filed 2026-08-05 | -$2.76M derived: sum of 3 quarters · filed 2026-08-05 | -$4.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$161.00K 10-Q · filed 2026-05-06 | -$183.00K derived: sum of 2 quarters · filed 2026-05-06 | -$1.59M derived: sum of 3 quarters · filed 2026-05-06 | -$3.30M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.43M derived: sum of 2 quarters · filed 2026-02-25 | -$3.14M derived: sum of 3 quarters · filed 2026-02-25 | -$2.58M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$3.12M derived: sum of 2 quarters · filed 2025-11-04 | -$2.56M 10-Q · filed 2025-11-04 | -$3.41M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$1.16M 10-Q · filed 2025-08-04 | -$2.00M derived: sum of 3 quarters · filed 2026-02-25 | -$590.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $559.00K 10-Q · filed 2025-05-06 | -$286.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.12M derived: sum of 3 quarters · filed 2026-02-25 | -$200.91M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$845.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $565.00K derived: sum of 2 quarters · filed 2026-02-25 | -$201.47M derived: sum of 3 quarters · filed 2026-02-25 | -$193.13M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$200.63M derived: sum of 2 quarters · filed 2024-11-07 | -$192.29M 10-Q · filed 2024-11-07 | -$191.16M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$202.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$193.70M 10-Q · filed 2024-08-06 | -$192.57M derived: sum of 3 quarters · filed 2025-02-25 | -$183.46M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $8.34M 10-Q · filed 2024-05-07 | $9.47M derived: sum of 2 quarters · filed 2025-02-25 | $18.58M derived: sum of 3 quarters · filed 2025-02-25 | $22.89M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $10.24M derived: sum of 2 quarters · filed 2025-02-25 | $14.55M derived: sum of 3 quarters · filed 2025-02-25 | $28.06M 10-K · filed 2025-02-25 |
| 2022-09-30 | $9.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $13.42M derived: sum of 2 quarters · filed 2023-11-02 | $26.93M 10-Q · filed 2023-11-02 | $37.34M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $17.82M 10-Q · filed 2023-08-03 | $28.23M derived: sum of 3 quarters · filed 2024-02-27 | $29.13M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $13.51M 10-Q · filed 2023-05-09 | $23.92M derived: sum of 2 quarters · filed 2024-02-27 | $24.82M derived: sum of 3 quarters · filed 2024-02-27 | $1.14B derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $11.31M derived: sum of 2 quarters · filed 2024-02-27 | $1.12B derived: sum of 3 quarters · filed 2024-02-27 | $1.15B 10-K · filed 2024-02-27 |
| 2021-09-30 | $896.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.11B derived: sum of 2 quarters · filed 2022-11-03 | $1.14B 10-Q · filed 2022-11-03 | $1.14B derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $1.11B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.14B 10-Q · filed 2022-08-04 | $1.14B derived: sum of 3 quarters · filed 2023-03-01 | $1.14B derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $30.30M 10-Q · filed 2022-05-05 | $29.54M derived: sum of 2 quarters · filed 2023-03-01 | $23.40M derived: sum of 3 quarters · filed 2023-03-01 | $27.55M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$760.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$6.90M derived: sum of 2 quarters · filed 2023-03-01 | -$2.75M derived: sum of 3 quarters · filed 2023-03-01 | $24.62M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$6.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$1.99M derived: sum of 2 quarters · filed 2021-10-28 | $25.38M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $4.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $31.52M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $27.37M 10-Q · filed 2021-05-26 | |||
| 2019-12-31 | $176.30M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |